ReviewInternational journal of hematology2020
Clinical value of measurable residual disease testing for multiple myeloma and implementation in Japan.
Hiroyuki TakamatsuPubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it